{"id":"W2154580171","doi":"10.1503/cmaj.080486","title":"Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis","year":2008,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":550,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pioglitazone; Rosiglitazone; Randomized controlled trial; Thiazolidinedione; Internal medicine; Confidence interval; Odds ratio; Observational study; Type 2 diabetes; Bone mineral; Meta-analysis; Bone density; Sitagliptin; Relative risk; Osteoporosis; Diabetes mellitus; Endocrinology; Insulin","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1026505898818651,"score_gpt":0.3939844182182322,"score_spread":0.2913338283363671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}